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Hypertension (HTN) requires urgent, uniform, and consistent attention across all frontiers 
of pediatric health care not only because of established links between the onset of 
HTN during one’s youth and its sustenance throughout adulthood but also because of 
the sequelae associated with the disease’s trajectory, such as cardiovascular disease, 
end organ damage, and decreased quality of life. Although national guidelines for the 
diagnosis and management of pediatric HTN have been available for nearly 40 years, 
knowledge and recognition of the problem by clinicians remain poor due to a host of 
influencing factors. The purpose of this article is to explicate key issues contributing 
to the inaccurate measurement of blood pressure and misclassification of HTN among 
children and to present strategies to address these issues.
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inTRODUCTiOn
Hypertension (HTN) requires urgent, uniform, and consistent attention across all frontiers of 
pediatric health care not only because of established links between the onset of HTN during one’s 
youth and its sustenance throughout adulthood but also because of the sequelae associated with 
the disease’s trajectory, such as cardiovascular disease (CVD), end organ damage, and decreased 
quality of life.
Between 2011 and 2014, the prevalence of HTN among children and adolescents aged 8–17 years 
was approximately 2.2% (1), a number similar to other chronic childhood illnesses that garner 
more attention, such as asthma (9%), autism (1%), or epilepsy (1%) (2). Up to 30% of newly 
diagnosed hypertensive children demonstrate significant target organ damage, particularly left 
ventricular hypertrophy (2). Pediatric HTN is an issue attracting attention on a national level, as 
the reduction of the proportion of children with HTN is an active objective of the Healthy People 
2020 movement (1).
Although national guidelines for the diagnosis and management of pediatric HTN have been 
available for nearly 40 years, knowledge and recognition of the problem by clinicians remain poor 
due to a host of influencing factors (3). Faulty blood pressure (BP) testing can lead to misdiagnosis 
and unnecessary treatment, so proper BP measurement methods are essential. To obtain accurate 
BP measurements, clinicians must consider the type of equipment to be used, training personnel 
on proper technique, the environment in which measurement is conducted, classification of BP 
according to recommendations, and assessment for factors that could affect BP. The purpose of 
this paper is to provide an overview of practice recommendations, including a discussion of 
factors that may impact a provider’s ability to appropriately assess pediatric patients for HTN.
TAble 1 | blood pressure measurement device selection.





•	 Appropriately sized cuff with 
bladder and inflation bulb
•	 Considered the “gold standard”
•	 Directly comparable to classification tables 
normative data
•	 Environmental concerns about mercury 
contamination
•	 Potential for error and bias
Aneroid 
sphygmomanometer
•	 Lever and bellow aneroid unit
•	 Stethoscope
•	 Appropriately sized cuff with 
bladder and inflation bulb
•	 Ecologically friendly alternative to mercury 
sphygmomanometer
•	 Tends to be less accurate than mercury
•	 Susceptible to reading errors resulting from 
trauma to the unit
•	 Requires regular calibration
•	 Potential for error and bias
Office oscillometric (single 
measure)
•	 Automated unit validated in 
pediatric populations
•	 Appropriately sized cuff
•	 Easier to use than sphygmomanometer
•	 Ecologically friendly
•	 Less susceptible to error and bias
•	 Easier to use in situations when auscultation is 
challenging
•	 Beneficial in situations when frequent 
measurement is necessary
•	 Cuff placement less critical
•	 Wide variation in devices
•	 Device should be validated in children prior to 
use
•	 Susceptible to inaccurate readings in 
certain situations
•	 Susceptible to movement artifact
Office oscillometric (serial 
measure)
•	 Automated unit validated in 
pediatric populations
•	 Appropriately sized cuff
•	 Can assist with accurate diagnosis of 
hypertension (HTN)
•	 Reduces effect of white-coat HTN and masked 
HTN
•	 Cost-effective alternative to ambulatory blood 
pressure monitor
•	 Few units validated in pediatric populations
Ambulatory •	 Automated unit for home 
use validated in pediatric 
populations
•	 Unit able to store and 
download data
•	 Appropriately sized cuff
•	 Can assist with accurate diagnosis of HTN
•	 Reduces effect of white-coat HTN and masked 
HTN
•	 Can identify non-dipping BP pattern
•	 Can monitor BP patterns over time
•	 May not be well tolerated in children
•	 Requires family training and cooperation
•	 Susceptible to misreporting
•	 Normative values differ by sex and race
•	 Requires consultation to pediatric HTN specialist
•	 Equipment and analysis can be costly
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PRACTiCe ReCOMMenDATiOnS
The United States Preventive Services Task Force states that the 
current evidence is insufficient to assess the balance of benefits 
and harms of screening for primary HTN in asymptomatic chil-
dren and adolescents to prevent subsequent CVD in childhood 
or adulthood (4). The lack of compelling evidence to universally 
screen healthy children was also highlighted in a review by 
Chiolero and colleagues (5). However, given the implications 
of HTN and CVD in adulthood, a lifespan approach of early 
screening has been advocated by the National Heart, Lung, and 
Blood Institute (NHLBI) (6) and the American Heart Association 
(AHA) (7).
The AHA (7), NHLBI (6, 8), and American Association of 
Pediatrics (9) recommend that children over 3 years and under 
18 years receive a BP measurement at least annually, and once 
during every health-care episode. Children under 3 years should 
have their BP measured in special circumstances such as a history 
of being very low birth weight, history of recurrent urinary tract 
infections, and congenital heart disease.
Device Selection
When selecting a device, clinicians must consider the neces-
sary equipment, advantages, and disadvantages associated with 
each option. The most commonly used devices are the mercury 
sphygmomanometer, the aneroid sphygmomanometer, the 
office oscillometric device (single and serial measure), and the 
ambulatory blood pressure monitor (ABPM). Table  1 outlines 
key considerations for each device.
The gold standard is auscultation using a mercury sphyg-
momanometer; NHLBI BP classification tables are based on 
auscultatory measurements (6, 7). Since use of an appropriately 
sized cuff is critical for accurate measurement, the AHA advises 
clinicians have the following cuff sizes on hand: newborn/pre-
mature infant (4 cm × 8 cm), infant (6 cm × 12 cm), older child 
(9  cm ×  18  cm), standard adult, large adult, and thigh for leg 
measurement or for children with large arms (7). The bladder 
width should be at least 40% of the patient’s arm circumference 
midway between the olecranon and acromion processes and 
should cover 80–100% of the circumference of the arm (6, 7).
While the mercury sphygmomanometer is considered the 
gold standard, concerns have arisen about mercury contamina-
tion leading to this device being banned in some locations (7). 
The aneroid sphygmomanometer is a more environmentally 
friendly alternative that uses metal bellows and levers to register 
pressure. However, the aneroid sphygmomanometer tends to be 
less accurate than the mercury sphygmomanometer and requires 
regular calibration. Wall-mounted aneroid units are less likely 
to be dropped or subject to trauma and are more accurate than 
mobile devices (10).
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To measure BP using either the mercury or aneroid sphyg-
momanometer, the clinician inflates a cuff to a pressure greater 
than the SBP, thus occluding the brachial artery, then gradually 
deflates the cuff to auscultate sounds using a stethoscope placed 
at the artery below the cuff. A disadvantage of both options is 
the potential for observer error, such as differences in training, 
terminal digit preference, and expectation bias due to knowledge 
of previous readings (5).
Oscillometric (automated) BP measurement devices have 
rapidly replaced sphygmomanometers in clinical practice. These 
devices are more ecologically friendly, easier to use, and eliminate 
potential sources of bias. Oscillometric devices are also beneficial 
in situations in which auscultation is challenging, such as with 
newborns and young infants, where device utilization requires 
tolerance of excessive motion, and in intensive care settings when 
repeated measurements are required (7, 11). However, there is 
wide variation in devices, arterial stiffness and wide pulse pressure 
can lead to inaccurate readings, and measurement is susceptible 
to movement artifact.
When selecting an oscillometric device, clinicians should 
seek instruments that have been validated in the pediatric 
population (6, 12). The Association for the Advancement of 
Medical Instrumentation and the British Hypertension Society 
each developed established protocols for validation, and more 
recently, the European Society of Hypertension Working Group 
on Blood Pressure Monitoring developed an International 
Protocol to validate BP measurement devices (7, 13). To assist 
clinicians in identifying devices that have been validated and 
recommended, the dabl Educational established a not-for-profit, 
foundation-funded website to provide up-to-date validation 
information on BP measurement devices1 (14). Clinicians may 
consult these tables to determine which devices are recom-
mended for use in children.
Serial-measure oscillometric devices are designed to obtain a 
series of BP measurements at intervals of 1  min or more with 
the patient seated alone in a quiet room in the office setting. 
The number of serial measurements varies by device, typically 
three to six, and an average is calculated. In adults, no significant 
difference has been found between BP classification using serial 
measurement technique versus 24-h ABPM. The serial measure 
oscillometric device, such as the BpTru, can substantially reduce 
the effect of white coat HTN and masked HTN and can be a 
cost-efficient alternative to ABPM (15–17). The BpTru has been 
validated in children aged 3–18 years (18).
In some cases, ABPM is warranted to obtain a more accurate 
representation of the BP. With this method, BP is measured 
repeatedly, usually over a 24-h period, and the measurements 
are stored and downloaded (6, 7). ABPM is indicated when 
white coat HTN is suspected, to identify a non-dipping pressure 
pattern, to monitor drug effects (6, 7), and in situations when 
it is necessary to monitor BP patterns, such as chronic kidney 
disease, autonomic dysfunction (6), target-organ damage, and 
low birth weight (12).
1 http://www.dableducational.org/welcome.html.
Various ABPMs are available, but few have been formally vali-
dated in children (11). Beyond ensuring validation of a device, 
clinicians should identify a monitor that is lightweight, able to 
tolerate movement, and has pediatric cuffs. Software should be 
programmable to measure every 15–20  min over 24-h period, 
and preferably, can provide a report with pediatric reference data 
(19). ABPM can be conducted with a wide age range of children 
(20), but may not be well tolerated in all children, requires family 
training and cooperation, is susceptible to misreporting (12), 
and equipment and monitoring procedures are costly. Further, 
normative values differ by sex, height, and race (21, 22).
Care of equipment
Equipment must be properly maintained to ensure accurate 
measurement. Hardware should be cleaned with disinfecting 
wipes, and ABPM cuff covers should be washed between patients 
(11). The column of mercury sphygmomanometers should 
be clean, should rise and fall freely, and the upper curve of the 
meniscus should rest at 0 mmHg. Aneroid and other non-mercury 
sphygmomanometers should be calibrated semiannually by con-
necting the manometer to mercury column or electronic testing 
device. The needle should rest at 0 mmHg and should read within 
4 mmHg of the mercury sphygmomanometer when inflated to 
100 and 200 mmHg (6, 7). Since various automated devices are 
available on the market, calibration should occur according to the 
manufacturer’s recommendations (11).
Performance Considerations
The use of proper technique when obtaining BP readings is vital 
in terms of obtaining an accurate measurement and essential in 
reducing procedure variability. When possible, the patient should 
be seated with the antecubital fossa supported at heart level. The 
patient’s feet should be on the floor, not dangling from an exam 
table. Clinicians should remove clothing that covers the location 
of the cuff. The patient’s legs should be uncrossed, with the back 
and arm supported (7). A cuff placed over clothing can cause a 
5–50 mmHg discrepancy in SBP, an unsupported back can cause 
a 6–10  mmHg discrepancy in SBP, and sitting with the arm 
unsupported can cause a 1–7 mmHg in SBP and a 5–11 mmHg 
discrepancy in DBP (23).
In addition to proper positioning, the patient should be in 
a quiet environment. The clinician should avoid overinflating 
the cuff, since an overly tight cuff can cause upset in young 
children. Avoid talking during measurement (7), since talking 
and active listening can cause a 10-mmHg discrepancy in SBP 
and DBP (23).
Using the appropriate cuff size is another critical factor, since 
a too-small cuff can lead to false high readings and a too-large 
cuff can lead to false low readings (6). A too-small cuff can cause 
a discrepancy of 10 mmHg in SBP and 2–8 mmHg in DBP (23). 
Standard cuff placement is the upper arm; the right arm is the 
preferred site for repeated measures to maintain consistency and 
for accurate comparison to standards (6). In some circumstances, 
such as arm fracture or in the case of acute illness, it may be neces-
sary to measure in an alternate site or position. It is important to 
note that pressures vary by location and position.
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bP Classification
Accurate BP classification requires assessment of the patient’s 
age, sex, and height (7). The clinician first determines the 
patient’s height percentile using Centers for Disease Control 
and Prevention growth charts, then the clinician refers to the 
NHLBI (6) standardized BP classification tables to categorize 
the BP as normotensive, prehypertensive, or hypertensive. The 
AHA and the NHLBI recommend the patient’s BP be measured 
and recorded at least twice at each occasion, and the average of 
SBP and DBP be recorded (6, 7). However, Becton and colleagues 
(24) conducted an evaluation of NHANES data and found that in 
greater than 90% of adolescents aged 13–18 years, the BP clas-
sification remained the same in repeat sequential measurements.
Once the BP is plotted on the appropriate table for age, sex, 
and height, the percentile ranking is assessed. A BP that falls 
below the 90th percentile is considered normotensive, while a 
BP that falls between the 90th and 95th percentile is classified 
as prehypertension. Further, adolescents with a BP greater than 
120/80 should also be considered prehypertensive. Patients with 
a BP that falls into the prehypertensive range should be reassessed 
and evaluated for other risk factors (6). A BP that, on repeated 
assessments, consistently falls equal to or greater than the 95th 
percentile for age, sex, and height is classified as hypertensive 
(6, 7). If a BP falls between the 95th percentile and the 99th per-
centile plus 5 mmHg, the measurement should be repeated on two 
additional occasions to confirm the classification. However, if the 
BP is greater than the 99th percentile plus 5 mmHg, the patient 
should be promptly referred to a specialist for evaluation (6).
Before diagnosing a patient as hypertensive, the elevated BP 
should be confirmed on repeat visits, as BP measurement is more 
accurate if averaged over weeks or months rather than at a single 
visit (6, 7). An exception for this recommendation is when a 
patient appears symptomatic or has a profoundly elevated BP, in 
which case the patient should be promptly referred for further 
evaluation.
Pediatric HTN experts have developed and validated quick 
reference tables that are easier to use in the busy clinic set-
ting than the complex NHLBI standardized BP classification 
tables. One example is “A Pocket Guide to Blood Pressure 
Measurement in Children” developed by the National High 
Blood Pressure Education Program Working Group on High 
Blood Pressure in Children and Adolescents (25). This reference 
guide is published online by the NHLBI2 and offers tips on 
measurement, classification, and interpretation, and a simpli-
fied table by age and height.
2 https://www.nhlbi.nih.gov/files/docs/bp_child_pocket.pdf.
Other Special Considerations
Clinicians must also assess for factors that could affect BP, such 
as routine or intermittent medication use, recent use of tobacco 
products, and consumption of a sodium-rich or high caffeine 
diet. Multiple over-the-counter, herbal, and prescription medica-
tions have the potential to elevate BP, including decongestants, 
ephedra, ginkgo, ginseng, senna, St. John’s wort, and oral contra-
ceptives. Clinicians should also consider whether the patient is 
being treated for ADHD, since some medications prescribed for 
this condition may elevate BP. It is also important to assess for use 
of illegal substances such as anabolic steroids, amphetamines, and 
cocaine, all of which can affect BP (26).
Use of tobacco products can cause masked HTN (7), and smok-
ing within 30 min of BP measurement can cause a 6–20 mmHg 
discrepancy in SBP (23). Clinicians should ask questions directed 
at determining recent tobacco use, but should also inquire about 
sustained tobacco use since this can cause arterial changes that 
may affect BP. Smoking in the home, by parents or other residents, 
should also be assessed, because secondhand smoke can increase 
BP (27). Clinicians should also consider e-cigarette use, which 
can increase the DBP; e-cigarette use tripled among middle and 
high school students from 2013 to 2014 (28).
Finally, clinicians should consider the effect of dietary habits 
and sleep habits when assessing BP. Increased consumption of 
processed foods and those high in sodium, and poor sleep are 
associated with an elevated SBP (12), and caffeine use has been 
associated with masked HTN (7).
COnClUSiOn
Given the implications of CVD in adulthood, a lifespan approach 
of early screening for HTN in children is essential in reducing 
the mortality and morbidity associated with vascular compro-
mise. While this article provides an overview of practice recom-
mendations, current guidelines are actively being revised and 
updated. Adherence to recommended pediatric HTN guidelines 
through the use of accurate screening measures and practices 
and remaining abreast of practice guideline updates is the first 
step down the path of healing.
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